SCHEMBL30316262

SCHEMBL30316262

FC1(CN2CCCCC2)CNC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24033161 0.98 TSHR (0.30) TSHR
Hydrochloric Acid SCHEMBL29134312 0.95
SCHEMBL24197132 0.79 HTR6 (0.31)
SCHEMBL26803559 0.78 ALDH1A1 (0.35) TSHR
SCHEMBL27097467 0.76 SLC6A2 (0.37) TSHRHRH3MEN1KMT2A
SCHEMBL23439643 0.75 LMNA (0.33) HRH3
SCHEMBL31637071 0.73 TSHR (0.40) TSHRHRH3MEN1KMT2A
SCHEMBL25338400 0.72 KDM4E (0.31) MEN1KMT2A
SCHEMBL23163792 0.70 TSHR (0.37) TSHRMEN1KMT2A
SCHEMBL25466870 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230099344-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF IRAK-4 ARVINAS OPERATIONS, INC. 2023-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230099344-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF IRAK-4 IRAK1, IRAK4, IRAK2 TSHR 3539/4885HRH3 3196/4885MEN1 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.